CytomX Therapeutics Inc (CTMX) is a biotechnology company listed on US.
Latest reported CTMX revenue for 2026-06-30 was $11.7M. Net income was -$38.9M. Revenue was up 13.8% from 2026-03-31 to 2026-06-30. CTMX currently screens at market cap $653.1M.
Use this CTMX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the CTMX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the CTMX SEC filings page. Lician reads the product cache first so this HTML stays unique to CytomX Therapeutics Inc even when a live quote feed is slow.
Latest cached year on this hub. Full CTMX income, balance, and cash tables.